What are the goals of this study?
To identify barriers to biomarker testing, provide education of clinical trials/biomarker testing, and evaluate the impact that clinical trial access to biomarker testing and immunotherapy has on outcomes among Black patients diagnosed with advanced or metastatic non-small cell lung cancer.
Why am I being asked to participate?
Black people (i.e., African Americans) are at a greater risk than white people of being diagnosed with advanced or metastatic non-small cell lung cancer and having a poor prognosis. The low participatory rates for Blacks in clinical trials for biomarker testing and immunotherapy warrants a deeper understanding of the barriers that this population faces. By participating in this study, you would be contributing to the wealth of information that stems from this study for finding ways to reduce barriers to improve access to clinical trials for lung cancer biomarker testing and immunotherapy that have the potential to save more lives.
How will I benefit from participating in this study?
By participating in this study, you will receive high quality care by leading experts in lung cancer and be closely monitored for changes in your health while undergoing lung cancer treatment with immunotherapy (e.g., pembrolizumab) and biomarker testing to inform treatment decisions and improve your chances of living longer.
What is involved in this study & what will I be asked to do?
You will be asked to complete a questionnaire prior to viewing an education video, during treatment, and after treatment. You will be asked to provide samples of blood, stool, and tissue (optional: only in the event that your cancer has worsen after completion of your treatment).
Can I stop participating in the study, and what are my rights?
Yes. You have the right to stop participating during any part of the study. Before agreeing to participate in the study, your medical provider or study coordinator will review the informed consent with you which is required for study participation.
Who do I contact if I should have any questions?
If you are a patient at Moffitt Cancer Center, contact Clinical Trials Screening Coordinator, Ana Aminpour, Anahid.Aminpour@moffitt.org or (813) 745-0287, or Clinical Research Coordinator, Charna Noel, Charna.Noel@moffitt.org or (813) 745-1889.
If you are a patient seeking care at a healthcare facility other than Moffitt Cancer Center, contact Go2 for Lung Cancer, Science and Research Specialist, Brittney Nichols, firstname.lastname@example.org or (202) 742-1425.